Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Sep 30, 2023. (Total: 221577Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 10 (of 10 Records)

Query Trace: Primary Myelofibrosis and TP53[original query]
Prevalence and prognostic impact of allelic imbalances associated with leukemic transformation of Philadelphia chromosome-negative myeloproliferative neoplasms.
Blood 2010 1 115 (14): 2882-90.
Thoennissen Nils H, Krug Utz O, Lee Dhong Hyun Tony, Kawamata Norihiko, Iwanski Gabriela B, Lasho Terra, Weiss Tamara, Nowak Daniel, Koren-Michowitz Maya, Kato Motohiro, Sanada Masashi, Shih Lee-Yung, Nagler Arnon, Raynaud Sophie D, Müller-Tidow Carsten, Mesa Ruben, Haferlach Torsten, Gilliland D Gary, Tefferi Ayalew, Ogawa Seishi, Koeffler H Phill
Genomic characterization in triple-negative primary myelofibrosis and other myeloid neoplasms with bone marrow fibrosis.
Annals of hematology 2019 8 98 (10): 2319-2328.
Alvarez-Larrán Alberto, López-Guerra Mónica, Rozman María, Correa Juan-Gonzalo, Hernández-Boluda Juan Carlos, Tormo Mar, Martínez Daniel, Martín Iván, Colomer Dolors, Esteve Jordi, Cervantes Francis
Copy number alterations and copy-neutral loss of heterozygosity in Ukrainian patients with primary myelofibrosis.
Experimental oncology 2019 Mar 41 (1): 53-56.
Poluben L, Bryke Ch R, Hsu Y, Shumeiko O, Neumerzhitska L, Klimuk B, Rybchenko L, Klymenko S, Balk S P, Fraenkel P
The Temporal Sequence and the Differences in Somatic Mutation Acquisition Determines Clinical Behaviors of JAK2-Positive Myeloproliferative Neoplasms.
Anticancer research 2019 Nov 39 (11): 6273-6282.
Byun Ja Min, Song Seulki, Koh Youngil, Yoon Sung-Soo, Kim Daeyo
A case of a primary myelofibrosis with progression and related literature review of progression phase genetics.
International journal of laboratory hematology 2021 7 43 Suppl 1 78-81.
Chen Dong, Fuda Franklin, Weinberg Ol
Impact of Integrated Genetic Information on Diagnosis and Prognostication for Myeloproliferative Neoplasms in the Next-Generation Sequencing Era.
Journal of clinical medicine 2021 Mar 10 (5): .
Lee Jong-Mi, Lee Howon, Eom Ki-Seong, Lee Sung-Eun, Kim Myungshin, Kim Yongg
Venetoclax with azacitidine or decitabine in blast-phase myeloproliferative neoplasm: A multicenter series of 32 consecutive cases.
American journal of hematology 2021 (7): 781-789.
Gangat Naseema, Guglielmelli Paola, Szuber Natasha, Begna Kebede H, Patnaik Mrinal M, Litzow Mark R, Al-Kali Aref, Foran James M, Palmer Jeanne M, Alkhateeb Hassan, Elliott Michelle A, Hanson Curtis A, Pardanani Animesh, Mannelli Francesco, Vannucchi Alessandro M, Tefferi Ayal
Clinical impacts of the mutational spectrum in Japanese patients with primary myelofibrosis.
International journal of hematology 2021 Jan .
Morishita Soji, Ochiai Tomonori, Misawa Kyohei, Osaga Satoshi, Inano Tadaaki, Fukuda Yasutaka, Edahiro Yoko, Ohsaka Akimichi, Araki Marito, Komatsu Nor
Clinical features and next-generation sequencing landscape of essential thrombocythemia, prefibrotic primary myelofibrosis, and overt fibrotic primary myelofibrosis: a Chinese monocentric retrospective study.
Journal of cancer research and clinical oncology 2022 6 .
Zhang Lan, Ye Xingnong, Luo Shuna, Xu Xiaofei, Wang Shengjie, Jin Keyi, Zheng Yan, Zhu Xiaoqiong, Chen Dan, Jin Jie, Huang Ji
[Clinical characteristics and prognostic factors of patients with Philadelphia-negative myeloproliferative neoplasm accelerated/blast phase].
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2023 6 44 (4): 276-283.
X Yan, T J Qin, B Li, S Q Qu, L J Pan, F H Li, N N Liu, Z J Xiao, Z F
TOP